Background: Medication-overuse headache is a common clinical entity, but neuroimaging studies investigating volumetric and microstructural alterations of the brain in medication-overuse headache are rare. Therefore, in the current longitidunal study we evaluated gray matter volume and white matter integrity in patients with medication-overuse headache before and after drug withdrawal. Methods: A prospective study evaluated 27 patients with medication-overuse headache and 27 age-, sex-, and educationmatched healthy adults. High-resolution T1-weighted magnetic resonance imaging and diffusion tensor imaging were obtained from the control group and medication-overuse headache patients before and six months after drug withdrawal. Tract-based spatial statistics of multiple diffusivity indices and voxel-based morphometry were employed to investigate white and gray matter abnormalities. Results: No correlation was found between age, gender, education and smoking status in both groups. The most commonly overused medications were simple analgesics (96.3%) and combined analgesics (3.7%). The mean duration of the history of medication overuse and headaches was 56.7 AE 63.5 months. White matter diffusional and gray matter morphological alterations including volume, fractional anisotropy, radial diffusivity, and axial diffusivity analyses showed no significant relationship in the patients before and six months after withdrawal of analgesics. Also no difference was observed between the patients versus controls. Conclusion: Our data demonstrated no structural alterations within the brain in medication-overuse headache.
Introduction
Medication-overuse headache (MOH) results from regular overuse of abortive medication, exceeding 10 or 15 days per month (depending on the analgesic), for more than three months. 1 Studies have shown there is an interaction between the medication used excessively and susceptible patients with primary headache disorders. In $80% of patients with MOH, migraine is the underlying primary headache disorder. 2 The majority of the remaining patients have tension-type headache or, more rarely, posttraumatic headache. 2, 3 Population-based prevalence studies demonstrate that about 1%-2% of the general population suffers from chronic daily headache combined with overuse of headache medication [4] [5] [6] [7] [8] but some studies found that MOH prevalence is as high as 11%-70% in people with chronic daily headache. network has been proposed to underlie MOH pathophysiology. 9, 10 Animals treated with analgesics as a model of MOH demonstrated increased pain perception, as manifested in terms of lower withdrawal reflex thresholds. 9 This change could be gradually reversed after stopping drug infusion, but a different study showed that sensitization may persist even after drug discontinuation. 10 Although the diagnosis of MOH is exclusively a clinical task, imaging studies may help us to learn more about the disease. Novel neuroimaging methods such as diffusion tensor imaging (DTI) and volumetric structural T1-weighted magnetic resonance imaging (MRI) can potentially disclose subtle alterations in the gray (GM) and white matter (WM) of the brain, which may provide clues to understanding more about the pathophysiology of this disorder. DTI data can be evaluated using a tract-based spatial statistics (TBSS) method to study diffusivity in all directions, and thus may reveal subtle differences in WM microstructure when group data are compared. Likewise, subtle differences in GM volume can be detected when T1-weighted volumetric data are analyzed using voxel-based morphometry (VBM). However, such studies are rather small, and findings in detail are inconsistent.
Structural neuroimaging methods have provided valuable information on chronic pain conditions. Studies from a wide variety of chronic pain conditions indicate that long-term exposure to pain might cause structural alterations in a number of brain regions.
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VBM is an objective and automated method of analyzing volume changes in the brain and is commonly used to assess GM structure. 12 However, to date, a small number of cross-sectional VBM studies investigated GM volume alterations in patients with MOH compared to controls and the findings were discrepant. 11 Some studies have reported functional and structural alterations in MOH, including orbitofrontal hypometabolism 11 and changes in GM volumes in several brain areas. GM volume changes included an increase in the striatum, thalamus, midbrain and fusiform gyrus 9, 13 as well as a decrease in prefrontal and insular regions including the midbrain and orbitofrontal cortex.
14 Evaluation of GM volume with VBM in MOH patients in comparison with episodic migraine patients and healthy controls failed to detect significant differences between the groups while the evaluation of whole-brain functional connectivity using functional MRI showed regional differences in connectivity, and the authors concluded that MOH was associated with functional alterations within intrinsic brain networks rather than with macrostructural changes. 15 DTI is a quantitative neuroradiological technique that presents the possibility of both detecting and quantifying the putative microstructural abnormalities of WM. Studies using various methods (e.g. histogrambased analysis, region of interest, or TBSS), exploring both whole brain and targeted brain areas, have reported changes in various DTI parameters of migraine patients. [16] [17] [18] [19] So far only one study is available regarding whole-brain WM alterations in patients with MOH and the authors did not find any significant differences in patients with MOH compared to controls. 20 This is an important void in the application of novel quantitative neuroimaging methods, especially considering that there is a current need to understand the neurobiological mechanisms of MOH as it is a common health problem.
The aim of our longitudinal case-control study was to find out if there were any changes in GM volume and WM integrity in patients with MOH compared to healthy controls before and after discontinuation of the overused headache medication.
Patients and methods
The studied group consisted of 27 consecutive patients followed and treated by the authors for MOH between May 2014 and June 2016, in a tertiary headache outpatient clinic. Patients attended in our headache clinic were referred from primary care, the emergency department, other health professionals, or self-referred. Only patients diagnosed with MOH according to the criteria of the International Headache Society 1 were included in the sample group presented. Among the 35 patients who entered the study, eight were excluded because they refused to undergo the second MRI scan. Exclusion criteria included pregnancy and breastfeeding, secondary headaches, history of other types of addiction (such as alcohol, sedative, cannabis and psychoactive substances), as well as any serious ongoing physical or psychiatric illness.
In addition, 27 sex-, age-, smoking status-, and education-matched healthy volunteers from hospital staff with similar demographic characteristics served as controls. The controls were evaluated during the same time period and had not been considered in other published analyses. The controls had no abnormality in neurological examination, had not suffered from primary headaches, and did not have any medical conditions that can cause brain abnormalities on MRI scans. Patients with any structural changes in conventional brain MRI such as birth defects, developmental deformities, stroke, vasculitis, tumor, or demyelinating diseases were not included. All MR images were evaluated by an experienced consultant in neuroradiology (FG; 24 years of experience). We conducted a detailed clinical evaluation in each patient including a thorough neurological history, structured headache interview by the authors, and a detailed neurological examination. All interviews regarding the headache evaluation were conducted by at least two independent neurologists (YB; 21 years of experience and HST; 16 years of experience) and a consensus was reached after clinical discussion among the authors. The study was approved by the institutional research ethics board and written informed consent was obtained from the patients and healthy participants.
Since eight patients refused to undergo the second MRI scan, complete clinical and imaging datasets could be obtained from 27 patients. The mean age of the patient sample (n ¼ 27) was 37.9 AE 11.0 years (range: 20-60 years; 21 women and six men). The 27 sex-and age-matched healthy volunteers comprised 22 women and five men; mean age ¼ 37.3 AE 7.9 years, range 20-60 years. The mean duration of school education was 7.8 AE 4.3 years (range: 5-16 years) in the patient group and 7.7 AE 2.8 years (range: 5-16 years) in the control group. Almost 41% of patients and 52% of healthy volunteers were active smokers. The age, gender, education and smoking status were very similar in both groups, and there was no significant difference between patients and healthy controls. None of the patients or controls abused alcohol.
Underlying primary headache was migraine (80% migraine without aura, 20% migraine with aura) in 20 patients (74%) with MOH, whereas it was chronic tension-type headache in seven patients (26%). The mean duration of primary headache disorder was 12.90 years (range 1-32 years) in migraine patients and 12.29 (range 2-34 years) in tension-type headache patients. There was no statistically significant difference in duration of reported primary headaches between migraine and tension-type headache patients (p ¼ 0.813). Of all patients, 70% described pressing headache. Throbbing headaches were reported in 22%, and 8.4% had stabbing headache. In 59% of the group, headaches were reported to be in the temporal region, whereas the remainder experienced headaches in the occipital (23%) and in the frontal (18%) regions. While the side of headache was predominantly bilateral in 21 patients (78%), six patients (22%) reported unilateral headaches. The mean of the visual analog scale (VAS) was 6.5 AE 1.0 before detoxification and prophylactic treatment of MOH. The mean duration of MOH was 7.2 years, range: 2-20 years. The most commonly used agents were simple analgesics (nonsteroidal antiinflammatory drugs, paracetamol) overused by 26 patients (96.3%), and combined analgesics by one patient (3.7%) (nonsteroidal anti-inflammatory drugs þ ergotamines). The mean number of tablets overused by a patient during a month was 60 AE 2.8 (range . The mean number of headache days/month reduced from 22.92 AE 4.8 to 2.92 AE 1.3 days/month (range: 1-5 days) at the end of one-year of follow-up (p ¼ 0.000). The patients had significantly more reduction in number of headache days per month at the end of follow-up. VAS mean significantly decreased from 6.5 AE 1.0 to 2.92 AE 1.3 at the end of one year.
Image acquisitions
Conventional MRI. MRI was performed in all patients before and six months after medication withdrawal. We obtained brain MRI images using a GE Optima 360 1. Image analysis DTI. DTI data were analyzed using Oxford Centre for Functional MRI of the Brain (FMRIB's) Diffusion Toolbox, which is part of FMRIB Software Library (FSL). 21 Motion and eddy current artifacts were corrected using FSL EDDY-CORRECT. A brain mask of the non-diffusion-weighted image was created using FSL's Brain Extraction Tool. 22 The diffusion tensor was then calculated with FSL DTIFIT for wholebrain volumes, and the resulting fractional anisotropy (FA) maps together with the axial diffusivity (AD) (1) and radial diffusivity (RD) ((2 þ 3)/2) maps were used in subsequent TBSS analysis.
Voxel-wise statistical analysis of the data was performed using TBSS. 23 FA data were aligned into a common space using a non-linear registration algorithm (FSL FNIRT) to register the images to the standard-space Montreal Neurological Institute (MNI) 152 template and upsampled to 1 Â 1 Â 1 mm 3 . Thereafter, the registered FA images were averaged to generate a cross-subject mean FA image, and then the mean FA image was applied to create a mean FA skeleton, which represents the main fiber tracks and the center of all fiber tracts common to the group. The skeleton was then thresholded at an FA value of 0.2, which limits the effects of poor alignment across individuals and reduces the likelihood of inclusion of GM and cerebrospinal fluid voxels in the skeleton. The skeleton that is now created contains WM tracts that are common to all participants. A ''distance map'' is then created that is used to project each FA image onto the mean FA skeleton that is common to all participants. AD and RD images were also aligned into the MNI space and projected onto the mean FA skeleton using the protocol of non-FA images in TBSS.
VBM. Structural data were analyzed with FSL-VBM, 24 an optimized VBM protocol 25 carried out with FSL tools. 21 First, structural images were brain-extracted and GM-segmented before being registered to the MNI 152 standard space using non-linear registration. 26 The resulting images were averaged and flipped along the x-axis to create a left-right symmetric, studyspecific GM template. Second, all native GM images were non-linearly registered to this study-specific template and ''modulated'' to correct for local expansion (or contraction) due to the non-linear component of the spatial transformation. The modulated GM images were then smoothed with an isotropic Gaussian kernel with a sigma of 3 mm.
Statistical analysis. The statistical analysis was performed with the Student's t-test, chi square test, and analysis of variance when appropriate, using SPSS 16.0 for Windows. Post-hoc comparisons were performed with the Bonferroni correction.
FA, AD and RD values and GM volume differences were analyzed by voxel-wise statistical analysis that was based on a non-parametric approach using permutation test theory with 5000 random permutations (randomize tool in FSL). 27 The Threshold-Free Cluster Enhancement (TFCE) method was used to define the clusters. 28 P values less than 0.05 were considered to indicate a significant difference. Crosssectional analyses contrasted between controls and MOH group members both at baseline and after six months. Longitudinal analyses contrasted within the MOH group (baseline and six-month acquisition) and analyzed using paired t-test with covariation for the clinical variables that differ between two scans (headache frequency and intensity of headaches scores). 
Results

DTI analysis
Discussion
In this longitudinal study, we examined WM and GM alterations throughout the brain in patients with MOH before and after detoxification of overused drugs using VBM and TBSS methods. All our patients overused simple analgesics (nonsteroidal anti-inflammatory drugs and paracetamol) and some of them have been on simple analgesics for as long as 15 years (mean ¼ 7.2 years, range: 2-20 years). We had only one patient overusing ergotamine together with a simple analgesic, but she was not representative of our sample.
The present study showed no significant WM diffusional and GM morphological alterations between patients and controls, nor in patients before and after withdrawal of analgesics.
While, until now, few studies evaluated the changes in GM volume in patients with MOH, only one study investigated whole-brain WM alterations in this group. To our knowledge, this is the first study evaluating the putative changes both of WM and GM in MOH. Our finding with respect to GM volume is inconsistent with several results from other VBM investigations. Riederer et al. provided some information regarding changes in GM volume in many cortical and subcortical structures in patients with MOH. In their study, the GM volume was found to be increased in the periaquaductal GM, thalamus, and ventral striatum, and decreased in the frontal regions, including the orbitofrontal cortex, anterior cingulate cortex, the left and right insula, and the precuneus. 14 Riederer et al. showed that only patients with significant clinical improvement after analgesic withdrawal had smaller midbrain GM volume, whereas patients without improvement did not. Also, patients without treatment response had less gray matter in the orbitofrontal cortex.
14 In a recent study, GM volume changes at multiple brain areas (decrease in the orbitofrontal cortex, left middle occipital gyrus, and increase in the left temporal pole/ parahippocampus) were observed in chronic migraine patients with medication overuse compared to chronic migraine patients without medication overuse. 29 Consistent with our study, Schmidt-Wilcke and colleagues, who focused on structures known to be involved in pain processing and used VBM for this purpose, reported a significant decrease in GM in 20 patients with chronic tension-type headache, but not in 20 patients with MOH. 30 Using VBM, Chanraud et al. found no significant GM volume changes in MOH patients compared to migraine patients while they showed regional differences in connectivity in functional MRI. 15 There might be several reasons for the discrepancy between our and Riederer's study.
14 First, microstructural features of GM in MOH seem to depend on the pharmacology of the overused substances. Riederer et al. found volumetric changes in GM in patients who overused mostly triptan in addition to simple analgesics. 14 Our findings suggest that simple analgesic overuse may not be associated with GM volumetric difference. The present study had the advantage of a patient population, not including triptan, opioid or barbiturate overuses, and this may predict a greater likelihood of treatment success.
Second, response rate might be related to the degree of morphological changes. All our patients were classified as responders and none had relapsed to MOH within the first year following treatment, while in Riederer's study the number of responders (n ¼ 10) and nonresponders (n ¼ 8) were quite similar and two responders had relapsed to MOH 12 months after detoxification. 14 Longitudinal studies have suggested that medications containing barbiturates and opioids are associated with the highest risk of developing MOH, while triptans and simple analgesics are associated with lower risk. 31, 32 It seems that the type of drug overused influences the prognosis. The main clinical findings of our study were that all patients experienced less headache frequency and intensity during prophylactic treatment. Preclinical evidence shows that chronic exposure to opiates can facilitate the nociceptive process and lead to a persistent pronociceptive trigeminal neural adaptation. 33 Also, prolonged exposure to triptans produces comparable alterations in the sensory system. Enhancement of the calcitonin gene-related peptide and nitric oxide systems has been observed in animals treated with triptans. 34 We suggest that only simple analgesic exposure affects the trigeminal nociceptive system and other brain areas involved in headache pathogenesis less than other medications. This may explain the high success rate and the significant relief of headache after discontinuation of overused medication. Single and simple analgesic overuse seems to be related to a lower relapse rate and better favorable outcome.
Third, the discrepancy might be due to different techniques used between the studies. Like Lai et al., 29 we obtained brain MRI images using a 1.5 T scanner while Riederer et al. used a 3T scanner.
14 GM volumetrics studies have been performed in various headache disorders. Using VBM, significant structural changes in GM were not found in patients with episodic migraine and controls. 35 An investigation using VBM of structural T1-weighted MRI scans clearly demonstrated a unilateral increase of GM in the posterior inferior hypothalamus in patients with cluster headaches compared to healthy volunteers. 36 Previous studies of WM investigations in chronic pain disorders using TBSS are few in number and data are quite heterogeneous. In our study, no significant differences were detected in whole-brain WM analysis of our patients with MOH. Recently, Michels et al. reported new data regarding WM changes in MOH patients. Using DTI and TBSS, they showed that WM integrity was disturbed in the insular cortex and parietal operculum in MOH. 20 However, their study had limitations since the patients with MOH were not scanned during pain-free intervals and DTI findings were reported at p < 0.001 uncorrected, as the sample size (n ¼ 12) was rather small. The results of the present study suggest that the brain WM microstructure is spared in MOH, as demonstrated by the absence of DTI abnormalities. This result could be interpreted in two different ways. First, MOH might be a purely functional disease without identifiable diffusivity. Second, diffusional changes are too subtle to allow us to delineate abnormalities using TBSS.
Earlier studies using TBSS analysis reported subtle WM abnormalities in other pain conditions including fibromyalgia, 37 complex regional pain, 38 cluster headache, 39 and temporomandibular disorders. 40 These alterations revealed by FA decrease have been detected in WM tracts involved in sensory, modulatory and cognitive functions. Patients with episodic migraine showed lower FA in the thalamocortical tract, trigeminothalamic tract and ventrolateral periaquaductal GM, 41 as well as reduced FA in the visual-motion processing network. 42 Using DTI in a cohort of chronic migraine patients, microstructural WM alterations were not detected in comparison with episodic migraine patients or healthy individuals. The authors concluded that chronic migraine does not seem to be a risk factor for progressive microstructural WM changes in DTI. 43 Parise et al. reported no diffusivity abnormalities of brain WM in trigeminal neuralgia, comparing patients with controls. 44 One of the strengths of this study is that it is a longitudinal study in which the patients were scanned before and after detoxification and followed clinically for one year. Most previous studies are not longitudinal and MOH patients were scanned only during pain attacks.
According to epidemiological studies, smoking is an important risk factor for headache chronification. 45 Previous data identified that smoking is significantly associated with regional GM loss in healthy smokers. 46 For this purpose, we matched the number of smokers with non-smokers in the patients and controls.
Studies have demonstrated that low socioeconomic status is associated with chronic headache and MOH. 47, 48 However, the educational level was very similar in our patients and control individuals and there was no statistical significance.
The findings of this study should be interpreted after consideration of the following limitations. First, use of a higher Tesla scanner would give more precise information regarding brain microstructure. Second, the sample size was relatively small, which may limit the robustness of the findings. Another limitation of the study is that our patients were not assessed for current depressive symptoms with a structured clinical interview. Depression is commonly seen in patients with chronic pain disorders, and we only excluded patients with medically treated depression. The present data, however, remain important since it is the first study evaluating combined GM and WM microstructure in patients with MOH.
In conclusion, we demonstrated no significant WM or GM alterations in MOH, suggesting that this is a functional rather than an identifiable microstructural disorder. This paper raises new questions for future research in the understudied field of neuroimaging biomarkers of chronic headache. The findings reported herein require independent replication from other global regions in patients with MOH.
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